Lime and the Downtown Austin Alliance partnered to launch a free training and safety campaign at Republic Park the first week of each month. The first installation of the First Ride Academy (FRA) ...

Plan a full day at Ohio’s massive year-round market, where aisles of vendors, local goods, and surprises keep you wandering.

Learn how to make a functional and stylish quick release keychain. This easy DIY tutorial encourages creativity while crafting a practical accessory you can use every day.

Step-by-step guide to creating a unique trilobite-shaped paracord key fob. Perfect for beginners, this tutorial shows how to craft a stylish and functional accessory quickly and easily.

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

It’s a good day to be the pharmaceutical giant Eli Lilly. Right now, Eli Lilly appears to be the leader in the GLP-1 race amid multiple difficult headwinds for Novo Nordisk. As of this writing, Novo ...

Novo Nordisk announced its CagriSema GLP-1 weight loss drug underperformed Eli Lilly's tirzepatide in a trial. Separately, Lilly announced patients can use a single injector to hold a month's supply ...

Eli Manning is not losing any sleep over his latest Pro Football Hall of Fame snub. Manning was not elected in his second year of eligibility, and the two-time Super Bowl champion quarterback with the ...

Eli Lilly LLY0.80%increase; green up pointing triangle received approval from the Food and Drug Administration for a label expansion of its weight-loss drug Zepbound, adding a new monthly delivery ...

UPPER MACUNGIE TWP., Pa. — Pharmaceutical giant Eli Lilly and Company is building a manufacturing campus in the Lehigh Valley, a multi-billion-dollar project that promises to create hundreds of new ...

In the lucrative obesity drug race, there is Eli Lilly — and then there's everybody else. A pair of headlines Monday reinforced Lilly's dominance: Its lone commercial rival, Novo Nordisk , released ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...